Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis

American Journal of Medicine

Volumn 122, Issue 3, 2009, Pages

  Buchwald, Henry ^a   Estok, Rhonda ^b   Fahrbach, Kyle ^b   Banel, Deirdre ^b   Jensen, Michael D ^c   Pories, Walter J ^d   Bantle, John P ^e   Sledge, Isabella ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNITED BIOSOURCE CORPORATION   (United States)

^c Mayo Clinic   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bariatric surgery; Biliopancreatic diversion duodenal switch; Gastric bypass; Gastroplasty; Laparoscopic adjustable gastric banding; Meta analysis; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CLINICAL FEATURE; CLINICAL TRIAL; DIABETIC PATIENT; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH BYPASS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 61549094077     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.09.041     Document Type: Article

References (38)

1. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
2. Ball C., Sackett D., Phillips B., et al., CEBM website. Levels of Evidence and Grades of Recommendation. Centre for Evidence-Based Medicine, October 2006. http://www.cebm.net/levels_of_evidence.asp Accessed January 2, 2007
3. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
4. Hedges L., and Olkin I. Random effects models for effect sizes. In: Hedges L., and Olkin I. (Eds). Statistical Methods for Metaanalysis 42 (1985), Academic Press, Orlando, FL 191-200
5. DerSimonian R., and Laird N. Metaanalysis in clinical trials. Control Clin Trials 7 (1986) 177-188
6. Cochran W.G. The comparison of percentages in matched samples. Biometrika 37 (1950) 256-266
7. Higgins J.P.T., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
8. Mokdad A.H., Ford E.S., Bowman B.A., et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23 (2000) 1278-1283
9. Engelgau M.M., Geiss L.S., Saaddine J.B., et al. The evolving diabetes burden in the United States. Ann Intern Med 140 (2004) 945-950
10. Cowie C.C., Rust K.F., Byrd-Holt D.D., et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 29 (2006) 1263-1268
11. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes. Diabetes Care 27 (2004) 1047-1053
12. Hossain P., Kawar B., and Nahas M.E. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 356 (2007) 213-215
13. The World Health Report 2006. Working Together for Health (2006), Geneva World Health Organization, Geneva, Switzerland
14. Worldwatch Institute. Chronic hunger and obesity epidemics eroding global progress. http://www.worldwatch.org/node/1672 Accessed January 2, 2007
15. World Health Organization. The global challenge of obesity, 2002. http://www.who.int/dietphysicalactivity/en/ Accessed January 2, 2007
16. Flegal K.M., Carol M.D., Kuczmarski R.J., and Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 22 (1998) 39-47
17. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
18. Mokdad A.H., Bowman B.A., Ford E.S., et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2001) 1195-1200
19. North American Association for the Study of Obesity (NAASO) and the National Heart, Lung, and Blood Institute (NHLBI). The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication #00-4084, Oct 2000.
20. NHANES III Public Use Data File. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Laboratory Data File (CD-ROM). Public Use Data File Documentation Number 76200. Hyattsville, MD: Centers for Disease Control and Prevention, 1996. Available from National Technical Information Service (NTIS), Springfield, VA.
21. Hu F.B., Manson J.E., Stampfer M.J., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345 (2001) 790-797
22. Manson J.E., Willett W.C., Stampfer M.J., et al. Body weight and mortality among women. N Engl J Med 333 (1995) 677-685
23. Burstein R., Epstein Y., Charuzi I., et al. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes Relat Metab Disord 19 (1995) 558-561
24. Abbasi F., Brown Jr. B.W., Lamendola C., et al. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40 (2002) 937-943
25. National Institutes of Health Consensus Development Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med 115 (1991) 956-961
26. CDC/NHANES. Overweight and obesity: Obesity trends: U.S. Obesity Trends 1985-2005. http://www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index.htm Accessed June 18, 2007
27. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it?. An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 (1995) 339-352
28. MacDonald K.G., Long S.D., Swanson M.S., et al. The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus. J Gastrointest Surg 1 (1997) 213-220
29. Schauer P.R., Burguera B., Ikramuddin S., et al. Effect of laparoscopic Roux-en-Y gastric bypass on Type 2 diabetes mellitus. Ann Surg 238 (2003) 467-484
30. Christou N.V., Sampalis J.S., Liberman M., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 (2004) 416-423
31. Flum D.R., and Dellinger E.P. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 199 (2004) 543-551
32. Pories W.J., and Albrecht R.J. Etiology of type II diabetes mellitus: role of the foregut. World J Surg 25 (2001) 527-531
33. Hickey M.S., Pories W.J., MacDonald Jr. K.G., et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut?. Ann Surg 227 (1998) 637-643
34. Gannon M.C., Nuttall F.Q., Lane J.T., et al. Effect of 24 hours of starvation on plasma glucose and insulin concentrations in subjects with untreated non-insulin-dependent diabetes mellitus. Metab Clin Exp 45 (1996) 492-497
35. Rubino F., Forgione A., Cummings D.E., et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244 (2006) 741-749
36. Arguelles-Sarmiento J., Barnal-Velasquez H., Andujo-Vasquez L., and Pories W.J. Control of Type 2 diabetes mellitus in non-obese patients with stomach sparing duodeno-jejunal exclusion (SSDJE): report of the first ten cases. Surg Obes Related Dis (2009) (in press)
37. Buchwald H., Estok R., Fahrbach K., Banel D., and Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142 (2007) 621-635
38. Dimick J.B., Welch H.G., and Birkmeyer J.D. Surgical mortality as an indicator of hospital quality. JAMA 292 (2004) 847-851